Anaemia predictors in patients with chronic hepatitis C treated with ribavirin and direct-acting antiviral agents
{{output}}
Objectives: Anaemia is the most common side effect associated with ribavirin (RBV). This study intended to assess its incidence and determine its predictive factors in patients with hepatitis C virus on RBV plus direct-acting ant... ...
